Short description
Biohaven is a clinical-stage biopharmaceutical company that discovers and develops therapies for people with debilitating diseases.
Last funding
No Way
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
New Haven, Connecticut, United States, North America
Founded on
January 1, 2022
Exited on
May 5, 2017
Went public on
May 5, 2017
Stock symbol
BHVN
Non-profit?
No
Acquired?
No
Employees count
251-500